Bioanalysis Zone’s Post

Want to learn more about the regulatory considerations for PK bioanalysis? Look no further and watch our on-demand panel discussion: overcoming the unique bioanalytical challenges of supporting complex, regulated clinical studies now >>> https://hubs.ly/Q02KcPv80

Stay in the loop! Explore how LC–MS, LBA and hybrid assays are currently being used to support clinical trials from a bioanalytical perspective, and their advantages and drawbacks in our upcoming panel discussion! Register now >>> https://hubs.ly/Q02KcT8_0

The intricacies of immunomodulation in clinical trials can be complex, but our latest issue of The Altascientist breaks them down for you, including the standard classes of immunomodulators, advanced bioanalytical methods, and case studies with practical insights. Whether you focus on PK/PD studies or assess safety, we provide the strategies you need for reliable, actionable results. #DrugDevelopment #ClinicalTrials #Bioanalysis

Missed our recent panel discussion? Catch up on the insights from top experts tackling the unique bioanalytical challenges in complex, regulated clinical studies. From LC-MS to hybrid assays, discover strategies to support your trials. Watch on-demand now! >>> https://hubs.ly/Q02YbSKz0

Beyond cardiac-specific therapies, every investigational drug has the potential to impact cardiac function, making QT monitoring a critical part of any drug development process. AliveCor’s medical-grade technology solution for cardiac safety empowers clinicians with real-time heart data while enabling patients to remotely participate in trials, improving engagement and compliance. Learn more:  https://lnkd.in/gVzNTtxm Also, check out our NEW BioPharma resources webpage for clinical research content, industry perspectives, key insights from experts, and more: https://lnkd.in/gBcEdGwb #ClinicalTrials #ClinicalResearch #ECG #CardiacMonitoring

Optimizing immunohistochemistry validation is essential for reliable biomarker detection in clinical settings. Robust validation protocols and strategic regulatory planning ensure assay reliability and compliance. Learn about the critical steps for successful clinical trials and assay commercialization by reading the full article. https://hubs.ly/Q02Z8Xv30 #IHC #Biomarkers #ClinicalTrials

Whether you’re starting to design your ADME screening cascade or if you are looking to predict clinical exposure (or anything in between) our expert team are here to guide you. Learn more in our webinar! #ADME #DMPK #bioanalysis #pharmacokinetics #freewebinar

Learn about ADME considerations from candidate selection through preclinical and clinical development in our upcoming webinar. Secure your spot now! https://okt.to/4ZGQdo

With just over a week remaining, there’s still time to register for our upcoming webinar, hosted by Thomas Pesnot (FRSC) and featuring keynote speaker Rob Riley. The focus will be on the ADMET Toolkit for Clinical Pharmacokinetics. We’d love to have you join us! Register here: https://lnkd.in/edkmpNF5 In this webinar, we’ll cover: What is ADMET, and why is it crucial for drug discovery? Why are predicted human PK and exposure essential for success? What are the main ADMET challenges? How to design an effective screening cascade. How to anticipate and address ADMET challenges with tailored solutions.

Scientists recently developed a high performance liquid chromatography–ultraviolet (HPLC–UV) method for measuring selpercatinib blood levels in hopes of simplifying therapeutic drug monitoring in clinical practice. Link: https://lnkd.in/dFtzVUtE